Afinitor
Afinitor is a oncology medication containing Everolimus, available as 5/10mg tablets.
- Category
- Oncology
- Active ingredient
- Everolimus
- Route
- Oral use
- Form
- Tablet
- Strengths
- 5/10mg
You will receive a quality generic equivalent, depending on stock.
Prescription rules on Afinitor vary by country.
Details
- Conditions
- Renal cell carcinoma · Breast cancer · Neuroendocrine tumours
- Therapeutic Class
- MTOR Inhibitor
- Pharmacological Class
- Antineoplastic Agent
- Minor Side Effects
- stomatitis, fatigue, rash
- Moderate Side Effects
- infections, pneumonitis, anaemia
- Dosage Forms
- Tablet
- Administration Route
- Oral use
- Prescription Status
- Prescription medicine
- Originator
- Novartis
- Onset Time
- varies per patient
- Duration
- 24 hours
- Storage Instructions
- Store below 25°C. Protect from light.
- Drug Interactions
- cytochrome p450 inhibitors, grapefruit
What you will receive
Afinitor is the originator brand name, made by Novartis. We use it here to identify the medicine only; we are not affiliated with Novartis and do not ship the original Afinitor.
- You receive a generic equivalent: the same active ingredient (Everolimus) at the same dose, mostly recognised Indian branded generics from vetted manufacturers.
- The exact brand supplied depends on what is in stock at the dispatching warehouse.
- A regulated generic matches the original ingredient for ingredient by legal standard.